Multicenter CT phantoms public dataset for radiomics reproducibility tests.


Journal

Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 21 08 2018
revised: 15 11 2018
accepted: 06 12 2018
pubmed: 11 1 2019
medline: 20 8 2019
entrez: 11 1 2019
Statut: ppublish

Résumé

The aim of this paper is to describe a public, open-access, computed tomography (CT) phantom image set acquired at three centers and collected especially for radiomics reproducibility research. The dataset is useful to test radiomic features reproducibility with respect to various parameters, such as acquisition settings, scanners, and reconstruction algorithms. Three phantoms were scanned in three independent institutions. Images of the following phantoms were acquired: Catphan 700 and COPDGene Phantom II (Phantom Laboratory, Greenwich, NY, USA), and the Triple modality 3D Abdominal Phantom (CIRS, Norfolk, VA, USA). Data were collected at three Dutch medical centers: MAASTRO Clinic (Maastricht, NL), Radboud University Medical Center (Nijmegen, NL), and University Medical Center Groningen (Groningen, NL) with scanners from two different manufacturers Siemens Healthcare and Philips Healthcare. The following acquisition parameter were varied in the phantom scans: slice thickness, reconstruction kernels, and tube current. We made the dataset publically available on the Dutch instance of "Extensible Neuroimaging Archive Toolkit-XNAT" (https://xnat.bmia.nl). The dataset is freely available and reusable with attribution (Creative Commons 3.0 license). Our goal was to provide a findable, open-access, annotated, and reusable CT phantom dataset for radiomics reproducibility studies. Reproducibility testing and harmonization are fundamental requirements for wide generalizability of radiomics-based clinical prediction models. It is highly desirable to include only reproducible features into models, to be more assured of external validity across hitherto unseen contexts. In this view, phantom data from different centers represent a valuable source of information to exclude CT radiomic features that may already be unstable with respect to simplified structures and tightly controlled scan settings. The intended extension of our shared dataset is to include other modalities and phantoms with more realistic lesion simulations.

Identifiants

pubmed: 30629299
doi: 10.1002/mp.13385
pmc: PMC6849778
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1512-1518

Subventions

Organisme : Dutch STW-Perspectief Research Program
ID : 14929
Organisme : Dutch STW-Perspectief Research Program
ID : 14930
Organisme : Dutch Cancer Society

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 The Authors Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.

Références

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):133-40
pubmed: 23064544
J Med Imaging (Bellingham). 2018 Jan;5(1):011020
pubmed: 29487877
Neuroinformatics. 2007 Spring;5(1):11-34
pubmed: 17426351
Mol Oncol. 2008 Aug;2(2):115-52
pubmed: 19383333
Cancer Imaging. 2016 Apr 11;16:10
pubmed: 27066905
J Digit Imaging. 2012 Oct;25(5):635-45
pubmed: 22349992
J Med Imaging (Bellingham). 2015 Oct;2(4):041002
pubmed: 26251842
BMJ. 2015 Jan 07;350:g7594
pubmed: 25569120
Transl Oncol. 2014 Feb 01;7(1):72-87
pubmed: 24772210
Semin Radiat Oncol. 2010 Jul;20(3):149-55
pubmed: 20685577
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
Phys Med Biol. 2016 Jul 7;61(13):R150-66
pubmed: 27269645
Transl Oncol. 2014 Feb 01;7(1):88-93
pubmed: 24772211
Br J Radiol. 2017 Feb;90(1070):20160665
pubmed: 27936886
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1143-1158
pubmed: 30170872
Radiother Oncol. 2018 Jun;127(3):370-373
pubmed: 29598835
Oncotarget. 2016 Nov 1;7(44):71440-71446
pubmed: 27669756
Med Phys. 2015 Dec;42(12):6784-97
pubmed: 26632036
Stud Health Technol Inform. 2014;205:166-70
pubmed: 25160167

Auteurs

Petros Kalendralis (P)

MAASTRO Clinic and School for Oncology and Development Biology (GROW), Maastricht University Medical Centre+, 6229 ET, Maastricht, The Netherlands.

Alberto Traverso (A)

MAASTRO Clinic and School for Oncology and Development Biology (GROW), Maastricht University Medical Centre+, 6229 ET, Maastricht, The Netherlands.

Zhenwei Shi (Z)

MAASTRO Clinic and School for Oncology and Development Biology (GROW), Maastricht University Medical Centre+, 6229 ET, Maastricht, The Netherlands.

Ivan Zhovannik (I)

MAASTRO Clinic and School for Oncology and Development Biology (GROW), Maastricht University Medical Centre+, 6229 ET, Maastricht, The Netherlands.
Department of Radiation Oncology, Radboud University Medical Center, 6525 GC, Nijmegen, The Netherlands.

René Monshouwer (R)

Department of Radiation Oncology, Radboud University Medical Center, 6525 GC, Nijmegen, The Netherlands.

Martijn P A Starmans (MPA)

Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, 3015 GD, Rotterdam, The Netherlands.
Department of Medical Informatics, Erasmus Medical Centre, 3015 GD, Rotterdam, The Netherlands.

Stefan Klein (S)

Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, 3015 GD, Rotterdam, The Netherlands.
Department of Medical Informatics, Erasmus Medical Centre, 3015 GD, Rotterdam, The Netherlands.

Elisabeth Pfaehler (E)

University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands.

Ronald Boellaard (R)

Department of Radiology and Nuclear Medicine, VU Medical Center, 1081 HV, Amsterdam, The Netherlands.

Andre Dekker (A)

MAASTRO Clinic and School for Oncology and Development Biology (GROW), Maastricht University Medical Centre+, 6229 ET, Maastricht, The Netherlands.

Leonard Wee (L)

MAASTRO Clinic and School for Oncology and Development Biology (GROW), Maastricht University Medical Centre+, 6229 ET, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH